| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $6.8M | +355.5% |
| Cost of Revenue | $5.9M | +121.8% |
| Gross Profit | $907K | +177.7% |
| R&D Expense | $28.2M | +9.0% |
| SG&A Expense | $32.4M | +17.9% |
| Operating Income | -$73.9M | -13.9% |
| Pre-tax Income | -$73.2M | -12.8% |
| Income Tax | $0 | — |
| Net Income | -$73.2M |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $117.5M | -37.7% |
| Accounts Receivable | $2.1M | +280.3% |
| Inventory | $4.6M | +7.2% |
| Current Assets | $128.7M | -34.8% |
| Total Assets | $134.1M | -33.8% |
| Current Liabilities | $8.8M | -44.1% |
| Total Liabilities | $10.3M | -36.4% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$72.3M | -53.3% |
| Capital Expenditures | $585K | -78.4% |
| Investing Cash Flow | -$585K | +78.4% |
| Financing Cash Flow | $7K | -100.0% |
| Free Cash Flow | -$72.9M | -46.2% |
| -12.8% |
| EPS (Basic) | -$1.04 | +94.1% |
| EPS (Diluted) | -$1.04 | +94.1% |
| Stockholders' Equity |
| $123.7M |
| -33.6% |